Prognostic factors in patients with resected pathologic (p-) T1-2N1M0 non-small cell lung cancer (NSCLC)
Open Access
- 1 May 2001
- journal article
- Published by Oxford University Press (OUP) in European Journal of Cardio-Thoracic Surgery
- Vol. 19 (5) , 555-561
- https://doi.org/10.1016/s1010-7940(01)00670-4
Abstract
Objectives: To clarify prognostic factors in resected pathologic (p-) T1-2N1M0 non-small cell lung cancer (NSCLC). Methods: A total of 95 consecutiveKeywords
This publication has 21 references indexed in Scilit:
- Surgery for non-small cell lung cancer: postoperative survival based on the revised tumor-node-metastasis classification and its time trend✩European Journal of Cardio-Thoracic Surgery, 2000
- Non-small Cell Lung CancerChest, 1999
- Prognostic Significance of Apoptotic Index in Completely Resected Non–Small-Cell Lung CancerJournal of Clinical Oncology, 1999
- Unfavorable Prognosis of Patients With Stage II Non-small Cell Lung Cancer Associated With Macroscopic Nodal MetastasesChest, 1999
- p53 Status Predicts the Efficacy of Postoperative Oral Administration of Tegafur for Completely Resected Non-small Cell Lung Cancer†Japanese Journal of Cancer Research, 1999
- Revisions in the International System for Staging Lung CancerChest, 1997
- Mutations of the p53 Gene as a Predictor of Poor Prognosis in Patients With Non-Small-Cell Lung CancerJNCI Journal of the National Cancer Institute, 1993
- Survival after resection of stage II non-small cell lung cancerThe Annals of Thoracic Surgery, 1992
- p53 function and dysfunctionCell, 1992
- Cyclin/PCNA is the auxiliary protein of DNA polymerase-δNature, 1987